Take part in a survey to help improve DBS technology

Europe

Author: Johanna Stiefler JohnsonPublished: 4 February 2021

Prep: Cook: Serves:

Do you have a DBS implant to treat Parkinson’s disease? A new survey by Belgian research company SUAZIO aims to understand the maintenance challenges of the therapy

SUAZIO is inviting people with Parkinson’s disease who have undergone deep brain stimulation (DBS) – a therapy which uses a small device to send electronic impulses to specific regions of the brain – to share their experiences in a new survey.

The survey aims to understand the potential maintenance challenges related to rechargeable DBS systems – focusing primarily on how participants interact daily with the implant and handle the upkeep required for rechargeable batteries. The survey will also explore participants’ levels of involvement in decision-making processes when choosing an implant.

Rémy Blain-Descormiers, project manager at SUAZIO, said: “It is very important to speak to the users – to not only discuss parameters and technicalities with physicians, but to understand how people with Parkinson’s disease feel about their implant, how they handle it every day and what burden it might represent. It is essential that we hear from them more than anybody else.

“We hope to understand how patients feel about having to recharge their device on a frequent basis – if it is something that they are happy about or not. And if not, if they are considering another treatment strategy that would fit better with their lifestyle and expectations.”

SUAZIO hopes this research will assist in “developing and promoting solutions that will be more tailored to patients’ needs in the future”.

The researchers are looking for participants from the UK, France, Germany and Spain, who have received a DBS implant in the last five years. The survey will be carried out via 30-minute telephone conversations, will offer compensation of €/£75 and is open until 26 February 2021 or until the quota is filled.

Find out more about taking part here: info@suazio.com. When emailing, include ‘1180 – DBS patient maintenance burden’ in the subject line.

For more information about deep brain stimulation technology, please visit Parkinson’s Europe website.

How a TikTok video inspired a new pill bottle design for Parkinson’s

Last Month

Next Month

Go Back

Share this story

Comments

Advances

5 things you might not know about DBS

Diving deeper into deep brain stimulation with Dr Lennart Stieglitz

“My hopes faded. I was desperately trying to provide for my family”

A window into the world of young-onset Parkinson’s

Advances

A future with fewer side effects for DBS-implanted patients

The future of DBS technology

Chemical used in dry cleaning may be associated with Parkinson’s disease

The chemical trichloroethylene (TCE) has been used across a number of industries: to decaffeinate coffee, degrease metal parts, remove stains and dry-clean clothing. It’s currently banned in the European Union and the US states New York and Minnesota, except for authorised industrial uses. Now, scientists led by Dr Ray Dorsey in the US have conducted new research claiming that TCE could be linked to an increased risk of Parkinson’s. Published in the ‘Journal of Parkinson’s Disease’, the study investigated case studies of seven people who were exposed to TCE prior to a Parkinson’s diagnosis – including basketball legend Brian Grant. The researchers “postulate that this ubiquitous chemical is contributing to the global rise of Parkinson’s and that TCE is one of its invisible and highly preventable causes”. They called for the cleaning of TCE-contaminated sites and for indoor air exposure to be diminished – as well as for further studies to be…

Could certain cancers be linked to Parkinson’s disease?

Previous research has suggested that people with Parkinson’s may generally be less likely to develop most cancers. However, a new international study has found a potential genetic link between certain types of cancer and the condition. The team analysed genetic data from genome-wide association studies – a research approach that aims to identify gene variations associated with disease risk – to recognise common genetic risk factors between cancer and Parkinson’s. The findings uncovered a genetic link between the condition and both prostate cancer and melanoma. Meanwhile, the sum of various gene variants (otherwise known as the polygenic risk score) that contribute to Parkinson’s was significantly associated with a higher risk of breast cancer. “Our results suggest the importance of shared genetic variants between Parkinson’s and some cancers,” the researchers concluded in the study, which was published in the medical journal ‘Movement Disorders’. They highlighted the need for further studies to…

Investigational Parkinson’s disease dementia therapy fails in clinical trial

Research into new potential therapies for people with Parkinson’s is complex, which means that not all clinical trials will successfully move on to the next phase. This proved to be the case for US biotech company Aptinyx, which announced that it will halt further development work on an investigational therapy following “disappointing” results in the second phase of its study. The research had set out to examine the effect of NYX-458 – an oral therapy created to modulate the activity of receptors in the brain that are responsible for communication between neurons. The aim of the therapy was to improve cognition in people with cognitive impairment linked to Parkinson’s or Lewy body dementia. Yet, when compared to a placebo, the therapy didn’t demonstrate “meaningful improvements” in cognitive function. Dr Andy Kidd, president and CEO at Aptinyx, said: “We are very disappointed that the results of this Phase 2 study did…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Comments
This field is for validation purposes and should be left unchanged.

Take part in a survey to help improve DBS technology

Europe

Author: Johanna Stiefler JohnsonPublished: 4 February 2021

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

sponsored article

Advances

5 things you might not know about DBS

Interviews

“My hopes faded. I was desperately trying to provide for my family”

sponsored article

Advances

A future with fewer side effects for DBS-implanted patients

Chemical used in dry cleaning may be associated with Parkinson’s disease

Could certain cancers be linked to Parkinson’s disease?

Investigational Parkinson’s disease dementia therapy fails in clinical trial

{title}

Subscribe

Take part in a survey to help improve DBS technology

Europe

Author: Johanna Stiefler JohnsonPublished: 4 February 2021

Last Month

Next Month

Share this story

Comments

Related articles

sponsored article

Advances

5 things you might not know about DBS

Interviews

“My hopes faded. I was desperately trying to provide for my family”

sponsored article

Advances

A future with fewer side effects for DBS-implanted patients

Chemical used in dry cleaning may be associated with Parkinson’s disease

Could certain cancers be linked to Parkinson’s disease?

Investigational Parkinson’s disease dementia therapy fails in clinical trial

{title}

Subscribe

Sign in